275 ANTI-TRANSFORMING GROWTH FACTOR-β ANTIBODY 1D11 SUPPRESSES THE INVASION OF HUMAN PROSTATE CANCER CELLS
Qiang Zhang,Brian Helfand,Lin Chen,Weijun Qin,Weipeng Zhang,Charles Brendler,Thomas Jiang,Shilajit D. Kundu,Lihua Zhu,Vidit Sharma,Sherin Randall-London,Bob Lee,Timothy Michael Kuzel,Ximing J. Yang,Borko Jovanovic,Yinglu Guo,James Kozlowski,Chung Lee
DOI: https://doi.org/10.1016/j.juro.2011.02.367
IF: 7.6
2011-01-01
The Journal of Urology
Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research1 Apr 2011275 ANTI-TRANSFORMING GROWTH FACTOR-β ANTIBODY 1D11 SUPPRESSES THE INVASION OF HUMAN PROSTATE CANCER CELLS Qiang Zhang, Brian Helfand, Lin Chen, Weijun Qin, Weipeng Zhang, Charles Brendler, Thomas Jiang, Shilajit D. Kundu, Lihua Zhu, Vidit Sharma, Sherin Randall-London, Bob Lee, Timothy Michael Kuzel, Ximing J. Yang, Borko Jovanovic, Yinglu Guo, James Kozlowski, and Chung Lee Qiang ZhangQiang Zhang Chicago, IL More articles by this author , Brian HelfandBrian Helfand Chicago, IL More articles by this author , Lin ChenLin Chen Chicago, IL More articles by this author , Weijun QinWeijun Qin Chicago, IL More articles by this author , Weipeng ZhangWeipeng Zhang Chicago, IL More articles by this author , Charles BrendlerCharles Brendler Chicago, Please choose an option below More articles by this author , Thomas JiangThomas Jiang New Brunswick, NJ More articles by this author , Shilajit D. KunduShilajit D. Kundu Chicago, IL More articles by this author , Lihua ZhuLihua Zhu Boston, MA More articles by this author , Vidit SharmaVidit Sharma Chicago, IL More articles by this author , Sherin Randall-LondonSherin Randall-London Chicago, IL More articles by this author , Bob LeeBob Lee Chicago, IL More articles by this author , Timothy Michael KuzelTimothy Michael Kuzel Chicago, IL More articles by this author , Ximing J. YangXiming J. Yang Chicago, IL More articles by this author , Borko JovanovicBorko Jovanovic Chicago, IL More articles by this author , Yinglu GuoYinglu Guo Beijing, China, People's Republic of More articles by this author , James KozlowskiJames Kozlowski Chicago, IL More articles by this author , and Chung LeeChung Lee Chicago, IL More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.367AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Metastases are responsible for disease specific mortality in men with prostate cancer (CaP). Previously, we reported that TGF-β induced vimentin expression is associated with the epithelial-to-mesenchymal transition (EMT) which is correlated with migration of CaP cells and a worse prognosis in clinical specimens obtained at prostatectomy. In this study, we explored whether a specific neutralizing anti-TGF-β antibody 1D11 inhibits the migratory and invasive potential of CaP cells. METHODS Cell invasion assays were performed using the human CaP cell lines DU145 and PC-3 in a 24-well matrigel transwell chamber (8-μm pore size; CytoSelectTM; Cell Biolabs). Four different treatment groups were assigned to each cell line: Group 1- no treatment (control); Group 2- treatment with TGF-β(10ng/mL) for 24 hours; Group 3- treatment with anti-TGF-β (1, −2, −3) neutralizing mAb clone 1D11 (5ug/mL) for 24 hours; and Group 4- treatment with ERK inhibitor U0126 5μM. After 24 hours of invasion, the invaded cells were counted with a light microscope under high magnification objective (x100) and were then lysed and measured at OD 560nm in a plate reader after treatment with the extraction solution. Furthermore, Western blot analyses were performed to evaluate the expression of vimentin in each treatment group. RESULTS An average of 82 cells/field were found to invade in the control group. In Group 2, there was a significant increase in the number of invaded cells (139.33/field) with TGF-β treatment. Invasion of PC3 cells was significantly inhibited by treatment of 1D11, (only 7.67 cells/field). The ERK inhibitor, U0126, was also associated with a significant decrease in the number of invasive cells (14.67 cells/field; Group 4). Consistent with the results of the migration assay, Western blot analyses showed that after treatment with TGF-β, the expression of vimentin increased by 2–2.5 folds. In contrast, with the treatment of 1D11 and U0126, the expression of vimentin was suppressed 70% and 40% respectively. Furthermore, treatment of 1D11 resulted in the 50% inhibition of p-ERK, which indicated that 1D11 may inhibit TGF-β induced vimentin through a p-ERK pathway. CONCLUSIONS We previously reported TGF-β induced EMT is associated with more aggressive CaP phenotypes. The present findings indicate that neutralization of tumor secreted TGF-β by 1D11 may inhibit TGF-β and ERK induced expression of vimentin. Phenotypically this results in the suppression of CaP migration. Our results suggest potential targets for the future development of effective anti-tumor therapeutic strategies. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e110-e111 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Qiang Zhang Chicago, IL More articles by this author Brian Helfand Chicago, IL More articles by this author Lin Chen Chicago, IL More articles by this author Weijun Qin Chicago, IL More articles by this author Weipeng Zhang Chicago, IL More articles by this author Charles Brendler Chicago, Please choose an option below More articles by this author Thomas Jiang New Brunswick, NJ More articles by this author Shilajit D. Kundu Chicago, IL More articles by this author Lihua Zhu Boston, MA More articles by this author Vidit Sharma Chicago, IL More articles by this author Sherin Randall-London Chicago, IL More articles by this author Bob Lee Chicago, IL More articles by this author Timothy Michael Kuzel Chicago, IL More articles by this author Ximing J. Yang Chicago, IL More articles by this author Borko Jovanovic Chicago, IL More articles by this author Yinglu Guo Beijing, China, People's Republic of More articles by this author James Kozlowski Chicago, IL More articles by this author Chung Lee Chicago, IL More articles by this author Expand All Advertisement Advertisement PDF DownloadLoading ...